Download presentation
Presentation is loading. Please wait.
Published byAri Pranoto Modified over 6 years ago
1
Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions Michele Piazza, MD, Francesco Squizzato, MD, Gaya Spolverato, MD, Luca Milan, MD, Stefano Bonvini, MD, Mirko Menegolo, MD, Franco Grego, MD, Michele Antonello, MD Journal of Vascular Surgery Volume 62, Issue 5, Pages e1 (November 2015) DOI: /j.jvs Copyright © 2015 Society for Vascular Surgery Terms and Conditions
2
Fig 1 Overall primary patency for 167 limbs treated with bare-metal stents (BMSs) or covered stents (CSs). Journal of Vascular Surgery , e1DOI: ( /j.jvs ) Copyright © 2015 Society for Vascular Surgery Terms and Conditions
3
Fig 2 Primary patency for 167 limbs treated with bare-metal stents (BMSs) or covered stents (CSs) stratified by TransAtlantic Inter-Society Consensus (TASC) for the Management of Peripheral Arterial Disease C and D lesions. ∗Standard error >10%. Journal of Vascular Surgery , e1DOI: ( /j.jvs ) Copyright © 2015 Society for Vascular Surgery Terms and Conditions
4
Fig 3 Primary patency between covered stents (CSs) and bare-metal stents (BMSs) for a subcategory of TransAtlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) D lesions, defined as long lesions involving both the common iliac artery (CIA) and the external iliac artery (EIA). ∗Standard error >10%. Journal of Vascular Surgery , e1DOI: ( /j.jvs ) Copyright © 2015 Society for Vascular Surgery Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.